Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tianyin Reports Successful Tender Process for Major Drug

publication date: Apr 22, 2009

Tianyin Pharmaceutical, Co. reported that it is very pleased with the results of the 2009 tender process recently completed for its flagship drug, Ginkgo Mihuan Oral Solution. Ginkgo Mihuan Oral Solution is a TCM used to treat sequelas of cerebral thrombosis, coronary heart diseases and myocardial infarction. It generated 26% of Tianyin’s revenues in the December quarter. More details...

Stock Symbol: (NYSE Amex: TPI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital